Definitive Contract 80NSSC26C0220
- Not listed
- This federal contract award was issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Chromologic LLC, doing business as Chromologic, a minority-owned small business. The $299,980.00 Firm Fixed Price contract is for the development of a "Highly-Efficient Isolation and Fidelity Differentiation of Exosomes (HIFIDE) from Bodily Fluids Kit" under the Small Business Innovation Research (SBIR) program. Chromologic has...
- <p>The Defense Shared Services Center awarded an $846,741 firm fixed-price definitive contract to Chromologic LLC for SBIR Phase II microorganism genome enrichment and amplification sequencing research on June 14, 2024, under a total small business set-aside. Ultimate completion is December 14, 2026. Place of performance is Monrovia, CA.</p>
- This federal contract award, with an ID of 80NSSC23PB390, was issued by the Shared Services Center, a civilian agency, to Chromologic LLC, a minority-owned small business, for a Small Business Innovation Research (SBIR) Phase I project titled "Microorganisms Genome Enrichment and Amplification Sequencing (MGEAS)". The contract, with a firm fixed price of $149,918.00 and a completion date of February 2, 2024, is designated as a total small business set-aside. The project aims to develop...
- This is a U.S. government contract awarded to Chromologic LLC, a minority-owned, for-profit limited liability company, for a Small Business Innovation Research (SBIR) Phase I project. The contract, valued at $167,497.00, is a firm fixed-price purchase order set aside for small businesses. The contract supports research and development activities in areas such as medical devices, pharmaceuticals, diagnostics, and countermeasures, leveraging Chromologic's expertise in biomedical engineering,...
- This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Chromologic LLC, a minority-owned, for-profit limited liability company. The $149,950.07 Firm Fixed Price contract is for the development of an "Automated, High Throughput, Microfluidic Assembly and Transfer of Synthetic Genomes (SynGen System)". The contract has a total small business set-aside designation. Chromologic is a manufacturer of...
- Chromologic LLC, a Monrovia, California-based minority-owned small business, was awarded a $1.1 million Small Business Innovation Research (SBIR) Phase II contract by the U.S. Army Research, Development and Engineering Command. The award, originally issued on September 21, 2023, has been modified to extend the period of performance through December 22, 2025. The contract is designated as a total small business set-aside and structured as a firm fixed-price definitive contract, reflecting the...
- The U.S. Army awarded a firm-fixed-price purchase order contract to Chromologic LLC, a minority-owned small business, for a Phase I Small Business Innovation Research (SBIR) project titled "Phase I Probabilistic Analysis for Next Generation Sequencing (PANGS)." The $167,450.97 contract was awarded on August 10, 2020, with an ultimate completion date of August 9, 2021. The contract is a total small business set-aside, indicating that it is reserved exclusively for small businesses....
- Chromologic LLC was awarded a firm fixed price, definitive contract valued at $149,949.58 by the Department of the Army Medical Command to conduct research under Phase I of the Small Business Innovation Research program. The contract has a total small business set aside designation and calls for Chromologic to perform work related to proposal number H171-002-0113 at its place of performance in Monrovia, California through April 2018. As a minority-owned, small business, Chromologic will leverage...
- This is a firm-fixed-price Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Chromologic LLC, a minority-owned small business located in Monrovia, California. The contract, valued at $1,099,884.66, is for Chromologic's Phase II SBIR (Small Business Innovation Research) effort on "Radioprotection by JP4-039-MLV Nanoparticle Drugs." The contract is a total small business set-aside and has an ultimate completion date of December 28, 2024. Chromologic is a...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Chromologic LLC, a minority-owned small business based in Monrovia, California. The contract has a firm fixed price of $149,823.91 and a completion date of April 24, 2018. As an SBIR Phase I award, this contract funds early-stage research and development efforts, likely focused on developing innovative medical technology solutions. Chromologic has a history of SBIR/STTR...
The Shared Services Center awarded a $224,988 definitive contract to Chromologic LLC for automated sample containment and enrichment for nanopore sequencing using traps (ASCENT) on September 30, 2026, under a total small business set-aside. Chromologic is a minority-owned, American Indian-owned, and Subcontinent Asian American-owned small business. This is a Small Business Innovation Research Phase I award with firm fixed-price terms and an ultimate completion date of March 30, 2027. Place of performance is Monrovia, CA. The originating solicitation seeks development of automated sample containment and enrichment technology to advance nanopore-based sequencing capabilities. Chromologic specializes in advanced biomedical and medical-device technologies for federal agencies, with a portfolio centered on radiation medical countermeasures, portable diagnostic devices, CRISPR-based assays, and microRNA biomarker development. The company operates predominantly as a prime contractor under small business set-asides across SBIR and STTR programs, with recent significant awards from the National Institute of Allergy and Infectious Diseases, Defense Health Agency, and Army Medical Command. Top NAICS categories reflect the vendor's research and development posture, with substantial biotechnology and life sciences work.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $225.0k | 9/8/26 |